Open AccessClinical Experience with Infliximab for Crohn’s Disease: The First 100 Patients in Edmonton, Alberta
Author(s) -
Clifford Sample,
Robert J. Bailey,
Dennis Todoruk,
Daniel Sadowski,
Leah Gramlich,
Mario Milan,
Raeleen Cherry,
Mang Ma,
Eoin Lalor,
John McKaigney,
Richard W. Sherbaniuk,
Kata Matic,
Connie Switzer,
Richard N. Fedorak
Publication year - 2002
Publication title -
canadian journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1916-7237
pISSN - 0835-7900
DOI - 10.1155/2002/379307
Subject(s) - infliximab , medicine , adverse effect , concomitant , crohn's disease , clinical trial , inflammatory bowel disease , disease , demographics , surgery , demography , sociology
To determine whether the clinical efficacy and safety of infliximab in diverse clinical referral practices was similar to that seen in the randomized, controlled clinical trials.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom